KeyBanc analyst Josh Beck lowered the firm’s price target on Bill to $95 from $100 and keeps an Overweight rating on the shares ahead of the quarterly earnings report on May 4. Three data sources have indicated sequential trends were down mid single to low double digits in Q1, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on BILL: